Gelatin-methacryloyl hydrogel based in vitro blood–brain barrier model for studying breast cancer-associated brain metastasis

References

• Agarwal KC, Parks RE. 1983. Forskolin: a potential antimetastatic agent. Int J Cancer. 32(6):801–804.
   PubMed Web of Science ®Google Scholar
• Alessio E, Mestroni G, Bergamo A, Sava G. 2004. Ruthenium antimetastatic agents. Curr Top Med Chem. 4(15):1525–1535.
   PubMed Web of Science ®Google Scholar
• Anderson RL, Balasas T, Callaghan J, Coombes RC, Evans J, Hall JA, Kinrade S, Jones D, Jones PS, Jones R. et al. 2019. A framework for the development of effective anti-metastatic agents. Nat Rev Clin Oncol. 16(3):185–204.
   PubMed Web of Science ®Google Scholar
• Augustine R, Hasan A, Dalvi Y B, Rehman S R U, Varghese R, Unni R N, Yalcin H C, Alfkey R, Thomas S, Al Moustafa A-E. 2021. Growth factor loaded in situ photocrosslinkable poly(3-hydroxybutyrate-co-3-hydroxyvalerate)/gelatin methacryloyl hybrid patch for diabetic wound healing. Materials Science and Engineering: C. 118:111519 doi:https://doi.org/10.1016/j.msec.2020.111519.
   PubMed Web of Science ®Google Scholar
• Augustine R, Zahid A A, Hasan A, Dalvi Y B, Jacob J. 2021. Cerium Oxide Nanoparticle-Loaded Gelatin Methacryloyl Hydrogel Wound-Healing Patch with Free Radical Scavenging Activity. ACS Biomater Sci Eng. 7(1):279–290. doi:https://doi.org/10.1021/acsbiomaterials.0c01138. 33320529
   PubMed Web of Science ®Google Scholar
• Augustine R, Alhussain H, Hasan A, Ahmed MB, Yalcin HC, Al Moustafa AE. 2020. A novel in ovo model to study cancer metastasis using chicken embryos and GFP expressing cancer cells. Bosn J Basic Med Sci. 20(1):140–148.
   PubMed Web of Science ®Google Scholar
• Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE. 2004. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol. 22(14):2865–2872.
   PubMed Web of Science ®Google Scholar
• Benam KH, Dauth S, Hassell B, Herland A, Jain A, Jang K-J, Karalis K, Kim HJ, MacQueen L, Mahmoodian R, et al. 2015. Engineered in vitro disease models. Annu Rev Pathol. 10:195–262.
   PubMed Web of Science ®Google Scholar
• Bersini S, Jeon JS, Moretti M, Kamm RD. 2014. In vitro models of the metastatic cascade: from local invasion to extravasation. Drug Discov Today. 19(6):735–742.
   PubMed Web of Science ®Google Scholar
• Bhowmik A, Khan R, Ghosh MK. 2015. Blood brain barrier: a challenge for effectual therapy of brain tumors. Biomed Res Int. 2015:320941–320920.
   PubMed Web of Science ®Google Scholar
• Brosnan EM, Anders CK. 2018. Understanding patterns of brain metastasis in breast cancer and designing rational therapeutic strategies. Ann Transl Med. 6(9):163–163.
   PubMed Web of Science ®Google Scholar
• Brown Chandler K, E. Costello C, Rahimi N. 2019. Glycosylation in the tumor microenvironment: implications for tumor angiogenesis and metastasis. Cells. 8(6):544.
   Web of Science ®Google Scholar
• Burns AR, Bowden RA, MacDonell SD, Walker DC, Odebunmi TO, Donnachie EM, Simon SI, Entman ML, Smith CW. 2000. Analysis of tight junctions during neutrophil transendothelial migration. J Cell Sci. 113(1):45–57.
   PubMed Web of Science ®Google Scholar
• Debeir OD, Decaestecker C, Debeir O, Adanja I, Kiss R. 2008. Models of cancer cell migration and cellular imaging and analysis. In: The motile actin system in health and disease. Vol. 661. Trivandrum, India: Transworld Research Network; p. 123–156.
   Google Scholar
• Domura R, Sasaki R, Okamoto M, Hirano M, Kohda K, Napiwocki B, Turng LS. 2017. Comprehensive study on cellular morphologies, proliferation, motility, and epithelial-mesenchymal transition of breast cancer cells incubated on electrospun polymeric fiber substrates. J Mater Chem B. 5(14):2588–2600.
   PubMed Web of Science ®Google Scholar
• Gandalovičová A, Rosel D, Fernandes M, Veselý P, Heneberg P, Čermák V, Petruželka L, Kumar S, Sanz-Moreno V, Brábek J. 2017. Migrastatics-anti-metastatic and anti-invasion drugs: promises and challenges. Trends Cancer. 3(6):391–406.
   PubMed Web of Science ®Google Scholar
• Goggins E, Kakkad S, Mironchik Y, Jacob D, Wildes F, Krishnamachary B, Bhujwalla ZM. 2018. Hypoxia inducible factors modify collagen I fibers in MDA-MB-231 triple negative breast cancer xenografts. Neoplasia. 20(2):131–139.
   PubMed Web of Science ®Google Scholar
• Hatherell K, Couraud PO, Romero IA, Weksler B, Pilkington GJ. 2011. Development of a three-dimensional, all-human in vitro model of the blood-brain barrier using mono-, co-, and tri-cultivation Transwell models. J Neurosci Methods. 199(2):223–229.
   PubMed Web of Science ®Google Scholar
• Honn KV, Cicone B, Skoff A. 1981. Prostacyclin: a potent antimetastatic agent. Science (80-). 212(4500):1270–1272.
   PubMed Web of Science ®Google Scholar
• Kasiotis KM, Magiatis P, Pratsinis H, Skaltsounis A-L, Abadji V, Charalambous A, Moutsatsou P, Haroutounian SA. 2001. Synthesis and biological evaluation of novel daunorubicin-estrogen conjugates. Steroids. 66(10):785–791.
   PubMed Web of Science ®Google Scholar
• Kessler L, Gehrke S, Winnefeld M, Huber B, Hoch E, Walter T, Wyrwa R, Schnabelrauch M, Schmidt M, Kückelhaus M, et al. 2017. Methacrylated gelatin/hyaluronan-based hydrogels for soft tissue engineering. J Tissue Eng. 8:1–14.
   Web of Science ®Google Scholar
• Khanna C, Hunter K. 2004. Modeling metastasis in vivo. Carcinogenesis [Internet]. 26(3):513–523.
   PubMed Web of Science ®Google Scholar
• Kim JI, Lakshmikanthan V, Frilot N, Daaka Y. 2010. Prostaglandin E2 promotes lung cancer cell migration via EP4-betaArrestin1-c-Src signalsome. Mol Cancer Res. 8(4):569–577.
   PubMed Web of Science ®Google Scholar
• Klotz BJ, Gawlitta D, Rosenberg AJWP, Malda J, Melchels FPW. 2016. Gelatin-methacryloyl hydrogels: towards biofabrication-based tissue repair. Trends Biotechnol. 34(5):394–407.
   PubMed Web of Science ®Google Scholar
• Langley RR, Fidler IJ. 2007. Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. Endocr Rev. 28(3):297–321.
   PubMed Web of Science ®Google Scholar
• Lécuyer MA, Kebir H, Prat A. 2016. Glial influences on BBB functions and molecular players in immune cell trafficking. Biochim Biophys Acta - Mol Basis Dis. 1862(3):472–482.
   PubMed Web of Science ®Google Scholar
• Li J, Zhang Y, Mao F, Lin Y, Xiao S, Xiang Z, Ma H, Zhang Y, Yu Z. 2018. The first morphologic and functional characterization of hemocytes in Hong Kong oyster, Crassostrea hongkongensis. Fish Shellfish Immunol. 81:423–429.
   PubMed Web of Science ®Google Scholar
• Liebner S, Dijkhuizen RM, Reiss Y, Plate KH, Agalliu D, Constantin G. 2018. Functional morphology of the blood-brain barrier in health and disease. Acta Neuropathol. 135(3):311–336.
   PubMed Web of Science ®Google Scholar
• Liu Q, Zhang Z, Liu Y, Cui Z, Zhang T, Li Z, Ma W. 2018. Cancer cells growing on perfused 3D collagen model produced higher reactive oxygen species level and were more resistant to cisplatin compared to the 2D model. J Appl Biomater Funct Mater. 16(3):144–150.
   PubMed Web of Science ®Google Scholar
• Malandrino A, Kamm RD, Moeendarbary E. 2018. In vitro modeling of mechanics in cancer metastasis. ACS Biomater Sci Eng. 4(2):294–301.
   PubMed Web of Science ®Google Scholar
• Man S, Ubogu EE, Williams KA, Tucky B, Callahan MK, Ransohoff RM. 2008. Human brain microvascular endothelial cells and umbilical vein endothelial cells differentially facilitate leukocyte recruitment and utilize chemokines for T cell migration. Clin Dev Immunol. 2008:384982.
   PubMedGoogle Scholar
• Mehlen P, Puisieux A. 2006. Metastasis: a question of life or death. Nat Rev Cancer. 6(6):449–458.
   PubMed Web of Science ®Google Scholar
• Modarres H P, Janmaleki M, Novin M, Saliba J, El-Hajj F, Rezayaticharan M, Seyfoori A, Sadabadi H, Vandal M, Nguyen M D, et al. 2018. In vitro models and systems for evaluating the dynamics of drug delivery to the healthy and diseased brain. J. Controlled Release. 273:108–130. doi:https://doi.org/10.1016/j.jconrel.2018.01.024.
   PubMed Web of Science ®Google Scholar
• Narkhede AA, Shevde LA, Rao SS. 2017. Biomimetic strategies to recapitulate organ specific microenvironments for studying breast cancer metastasis. Int J Cancer. 141(6):1091–1109.
   PubMed Web of Science ®Google Scholar
• Nichol JW, Koshy ST, Bae H, Hwang CM, Yamanlar S, Khademhosseini A. 2010. Cell-laden microengineered gelatin methacrylate hydrogels. Biomaterials. 31(21):5536–5544.
   PubMed Web of Science ®Google Scholar
• Pelham RJ, Wang Y. l. 1997. Cell locomotion and focal adhesions are regulated by substrate flexibility. Proc Natl Acad Sci USA. 94(25):13661–13665.
   PubMed Web of Science ®Google Scholar
• Pestalozzi BC, Holmes E, de Azambuja E, Metzger-Filho O, Hogge L, Scullion M, Láng I, Wardley A, Lichinitser M, Sanchez RIL, et al. 2013. CNS relapses in patients with HER2-positive early breast cancer who have and have not received adjuvant trastuzumab: a retrospective substudy of the HERA trial (BIG 1-01). Lancet Oncol. 14(3):244–248.
   PubMed Web of Science ®Google Scholar
• Raimondi C, Gradilone A, Naso G, Vincenzi B, Petracca A, Nicolazzo C, Palazzo A, Saltarelli R, Spremberg F, Cortesi E, et al. 2011. Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients. Breast Cancer Res Treat. 130(2):449–455.
   PubMed Web of Science ®Google Scholar
• Ravi M, Paramesh V, Kaviya SR, Anuradha E, Paul Solomon FD. 2015. 3D cell culture systems: advantages and applications. J Cell Physiol. 230(1):16–26.
   PubMed Web of Science ®Google Scholar
• Rodrigues T, Kundu B, Silva-Correia J, Kundu SC, Oliveira JM, Reis RL, Correlo VM. 2018. Emerging tumor spheroids technologies for 3D in vitro cancer modeling. Pharmacol Ther. 184:201–211.
   PubMed Web of Science ®Google Scholar
• Singh P, Singh A. 2012. Ocular adverse effects of anti-cancer chemotherapy. J Cancer Ther Res. 1(1):5–5.
   Google Scholar
• Sledge GW, Loehrer PJ, Roth BJ, Einhorn LH. 1988. Cisplatin as first-line therapy for metastatic breast cancer. J Clin Oncol. 6(12):1811–1814.
   PubMed Web of Science ®Google Scholar
• Sobierajska K, Ciszewski WM, Wawro ME, Wieczorek-Szukała K, Boncela J, Papiewska-Pajak I. 2019. TUBB4B downregulation is critical for increasing migration of metastatic colon cancer cells. Cells. 8:810.
   Web of Science ®Google Scholar
• Stone NL, England TJ, O’Sullivan SE. 2019. A novel transwell blood brain barrier model using primary human cells. Front Cell Neurosci. 13:230.
   PubMed Web of Science ®Google Scholar
• Tominaga N, Kosaka N, Ono M, Katsuda T, Yoshioka Y, Tamura K, Lötvall J, Nakagama H, Ochiya T. 2015. Brain metastatic cancer cells release microRNA-181c-containing extracellular vesicles capable of destructing blood-brain barrier. Nat Commun. 6:6716
   PubMed Web of Science ®Google Scholar
• Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinänen R, Palmberg C, Palotie A, Tammela T, Isola J, Kallioniemi OP. 1995. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat Genet. 9(4):401–406.
   PubMed Web of Science ®Google Scholar
• Wang Y, Ma M, Wang J, Zhang W, Lu W, Gao Y, Zhang B, Guo Y. 2018. Development of a photo-crosslinking, biodegradable GelMA/PEGDA hydrogel for guided bone regeneration materials. Materials (Basel). 11(8):1345.
   PubMed Web of Science ®Google Scholar
• Wilhelm I, Molnár J, Fazakas C, Haskó J, Krizbai IA. 2013. Role of the blood-brain barrier in the formation of brain metastases. Int J Mol Sci. 14(1):1383–1411.
   PubMed Web of Science ®Google Scholar
• Yue K, Trujillo-de Santiago G, Alvarez MM, Tamayol A, Annabi N, Khademhosseini A. 2015. Synthesis, properties, and biomedical applications of gelatin methacryloyl (GelMA) hydrogels. Biomaterials. 73:254–271.
   PubMed Web of Science ®Google Scholar